1.Results of 6 month short course chemotherapy for pulmonary tubercul-osis with 2SHRZ/4HR.
Hyong Ju LEE ; Chul Hong MIN ; Sun Woo LEE ; In Won PARK ; Byoung Whui CHOI ; Sung Ho HUE
Tuberculosis and Respiratory Diseases 1991;38(2):93-98
No abstract available.
Drug Therapy*
2.Adverse factors of hepatic dysfunction during chemotherapy for childhood malignancy.
Dong Hoon KOH ; Hyung Jong LIM ; Young Kwon CHOI ; Hoon KOOK ; Tae Joo HWANG
Journal of the Korean Cancer Association 1993;25(3):417-422
No abstract available.
Drug Therapy*
3.A case of simultaneous presentation of symptomatic PCM and MDS unrelated to prior chemotherapy.
Hyerim KIM ; Sang Hyuk PARK ; Eun Yup LEE ; Moo Kon SONG
Blood Research 2015;50(3):179-181
No abstract available.
Drug Therapy*
4.Clinical evaluation of a totally implantable venous access system for long-term anticancer chemotherapy.
Tejune CHUNG ; Won Sang CHUNG ; Young Hak KIM
Journal of the Korean Cancer Association 1991;23(2):424-428
No abstract available.
Drug Therapy*
5.Chemotherapy.
Journal of the Korean Gastric Cancer Association 2002;2(3):133-135
No abstract available.
Drug Therapy*
6.Complications of early postoperative intraperitoneal chemotherapy.
Journal of the Korean Cancer Association 1991;23(4):821-827
No abstract available.
Drug Therapy*
7.Pathological observations in locally advanced gastric carcinomas after preoperative chemotherapy.
Kyung Ja CHO ; Ja June JANG ; Chang Won HA ; Jae Soo KOH ; Jong In LEE ; Dong Wook CHOI ; Yoon Koo KANG
Journal of the Korean Cancer Association 1992;24(4):541-548
No abstract available.
Drug Therapy*
8.Results and toxicities of chemotherapy according to modality in high -risk metastatic GTN.
Hea Seung LEE ; Tchan Kyu PARK ; Dong Hee CHOI ; Jae Wook KIM ; Chang Hoon LEE
Korean Journal of Obstetrics and Gynecology 1992;35(3):379-387
No abstract available.
Drug Therapy*
9.Individualization of drug therapy: an historical perspective.
Translational and Clinical Pharmacology 2014;22(2):52-54
No abstract available.
Drug Therapy*
10.A clinical analysis for indication of intraperitoneal chemotherapy.
Young Tae KIM ; Byeong Ryong SEOL
Journal of the Korean Surgical Society 1993;44(3):414-421
No abstract available.
Drug Therapy*
Result Analysis
Print
Save
E-mail